Your browser doesn't support javascript.
loading
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A.
Brown, Anna-Leigh; Wilkins, Oscar G; Keuss, Matthew J; Hill, Sarah E; Zanovello, Matteo; Lee, Weaverly Colleen; Bampton, Alexander; Lee, Flora C Y; Masino, Laura; Qi, Yue A; Bryce-Smith, Sam; Gatt, Ariana; Hallegger, Martina; Fagegaltier, Delphine; Phatnani, Hemali; Newcombe, Jia; Gustavsson, Emil K; Seddighi, Sahba; Reyes, Joel F; Coon, Steven L; Ramos, Daniel; Schiavo, Giampietro; Fisher, Elizabeth M C; Raj, Towfique; Secrier, Maria; Lashley, Tammaryn; Ule, Jernej; Buratti, Emanuele; Humphrey, Jack; Ward, Michael E; Fratta, Pietro.
Afiliação
  • Brown AL; UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Wilkins OG; UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Keuss MJ; The Francis Crick Institute, London, UK.
  • Hill SE; UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Zanovello M; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • Lee WC; UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Bampton A; UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Lee FCY; Queen Square Brain Bank, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Masino L; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Qi YA; UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Bryce-Smith S; The Francis Crick Institute, London, UK.
  • Gatt A; The Francis Crick Institute, London, UK.
  • Hallegger M; Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.
  • Fagegaltier D; UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Phatnani H; Queen Square Brain Bank, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Newcombe J; UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Gustavsson EK; The Francis Crick Institute, London, UK.
  • Seddighi S; Center for Genomics of Neurodegenerative Disease, New York Genome Center (NYGC), New York, NY, USA.
  • Reyes JF; Center for Genomics of Neurodegenerative Disease, New York Genome Center (NYGC), New York, NY, USA.
  • Ramos D; NeuroResource, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK.
  • Schiavo G; Queen Square Brain Bank, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Fisher EMC; Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, University College London, London, UK.
  • Raj T; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • Secrier M; Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lashley T; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • Ule J; Molecular Genomics Core, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA.
  • Buratti E; National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
  • Humphrey J; Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.
  • Ward ME; UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
  • Fratta P; UK Dementia Research Institute, University College London, London, UK.
Nature ; 603(7899): 131-137, 2022 03.
Article em En | MEDLINE | ID: mdl-35197628
Variants of UNC13A, a critical gene for synapse function, increase the risk of amyotrophic lateral sclerosis and frontotemporal dementia1-3, two related neurodegenerative diseases defined by mislocalization of the RNA-binding protein TDP-434,5. Here we show that TDP-43 depletion induces robust inclusion of a cryptic exon in UNC13A, resulting in nonsense-mediated decay and loss of UNC13A protein. Two common intronic UNC13A polymorphisms strongly associated with amyotrophic lateral sclerosis and frontotemporal dementia risk overlap with TDP-43 binding sites. These polymorphisms potentiate cryptic exon inclusion, both in cultured cells and in brains and spinal cords from patients with these conditions. Our findings, which demonstrate a genetic link between loss of nuclear TDP-43 function and disease, reveal the mechanism by which UNC13A variants exacerbate the effects of decreased TDP-43 function. They further provide a promising therapeutic target for TDP-43 proteinopathies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Demência Frontotemporal / Proteinopatias TDP-43 / Esclerose Lateral Amiotrófica Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Demência Frontotemporal / Proteinopatias TDP-43 / Esclerose Lateral Amiotrófica Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article